Haupt Pharma at the ICSE - Contract manufacturing and development at the highest level confirmed by successful completion of an FDA audit
7.09.2010
Wolfratshausen, September 7, 2010 – At the international trade fair for pharmaceutical outsourcing, i.e. the International Contract Services Expo (ICSE) in Paris from October 5 to 7, the Haupt Pharma Group, one of the largest...[more]
Flexible and fast blister line for packaging cytostatics and immunosuppressives
6.09.2010
Haupt Pharma Amareg has put a new Uhlmann blister line into operation for packaging cytostatics and immunosuppressives. This line allows the packaging of tablets or capsules in PVC/PVDC aluminium or alternatively in...[more]
Hans-Christian Semmler has resigned from his position as Chief Executive Officer of Haupt Pharma AG
27.08.2010
With effect from August 26th, 2010 Mr Hans-Christian Semmler has resigned from his position as Chief Executive Officer (CEO) of Haupt Pharma AG. The Supervisory Board would like to thank Mr Semmler for the excellent work he has...[more]
In August 2010 Dr. Stephan Effenberger was appointed Managing Director of Haupt Pharma Amareg
1.08.2010
Board of Directors has appointed Dr. Stephan Effenberger new Managing Director of Haupt Pharma Amareg, effective August 1st, 2010.
He will succeed Dr. Andresen who was engaged for the production sites in Gronau and Regensburg...[more]
Dietmar Rohleder becomes CFO of Haupt Pharma AG
18.06.2010
Mr Dietmar Rohleder was appointed to the position of chief financial officer of Haupt Pharma AG by the Supervisory Board with effect from 17 June 2010.
Mr Rohleder takes over responsibility for the areas of finance, accounting...[more]
Increased capacity due to new laboratories for analytical development
17.06.2010
In April 2010, Haupt Pharma Amareg inaugurated several new purpose-built laboratories for pharmaceutical development, and in so doing increased its capacity for analytical development projects.
These new laboratories are...[more]
Mr. Yanagisawa becomes Managing Director of Haupt Pharma Toride Co., Ltd.
18.05.2010
In May 2010 Mr. Yanagisawa was appointed Managing Director of Haupt Pharma Toride.
Mr. Yanagisawa did a Bachelor of Arts in European History in Japan as well as a Master of Business Administration in the USA. He has an extensive...[more]
Giuseppe Martelli appointed new Managing Director of Haupt Pharma Latina S.r.l.
12.05.2010
Board of Directors has appointed Giuseppe Martelli new Managing Director of Haupt Pharma Latina, effective May 11th, 2010.
Giuseppe Martelli was born in 1967 in Locri, Italy. Mr. Martelli holds a degree in Industrial Chemistry...[more]
Successful FDA inspection at Italian site
16.02.2010
Haupt Pharma, one of Europe's leading contract developers and manufacturers, has undergone a successful inspection by the US Food and Drug Administration (FDA) at its Italian site without any FDA-483 observation being...[more]
